Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$427K Hold
2,059
0.05% 181
2018
Q2
$380K Hold
2,059
0.04% 186
2018
Q1
$351K Hold
2,059
0.04% 182
2017
Q4
$358K Buy
2,059
+19
+0.9% +$3.36K 0.04% 188
2017
Q3
$380K Hold
2,040
0.04% 182
2017
Q2
$351K Buy
2,040
+695
+52% +$113K 0.05% 177
2017
Q1
$221K Sell
1,345
-250
-16% -$41.5K 0.03% 200
2016
Q4
$233K Sell
1,595
-101
-6% -$15.2K 0.03% 200
2016
Q3
$283K Hold
1,696
0.04% 200
2016
Q2
$258K Buy
1,696
+110
+7% +$17.1K 0.03% 203
2016
Q1
$238K Hold
1,586
0.03% 202
2015
Q4
$257K Sell
1,586
-328
-17% -$51.6K 0.04% 199
2015
Q3
$265K Buy
1,914
+16
+0.8% +$2.52K 0.04% 198
2015
Q2
$291K Hold
1,898
0.04% 187
2015
Q1
$303K Buy
1,898
+101
+6% +$15.9K 0.04% 189
2014
Q4
$287K Buy
+1,797
New +$280K 0.04% 191

Other funds holding AMGN

Rand Wealth's AMGN Position: Q3 2018 in Review

Rand Wealth held its Amgen (AMGN) position steady in Q3 2018 at 2,059 shares worth $427K. The position accounts for 0.05% of the portfolio, ranked #181.

Rand Wealth first reported a position in AMGN in Q4 2014 and has held it in 16 quarters since. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Rand Wealth held 2,059 shares of Amgen worth $427K as of Q3 2018.
  • Rand Wealth left its Amgen share count unchanged in Q3 2018.
  • Amgen made up 0.05% of Rand Wealth's portfolio in Q3 2018, its #181 holding.
  • Rand Wealth first reported a position in Amgen in Q4 2014 and has held it in 16 quarters since.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.